Today: 21 May 2026
Browse Category

LSE:MNG 29 December 2025 - 12 March 2026

UK Stock Market Today: FTSE 100 Slides as Oil Jumps, BoE Cut Bets Take Another Hit

UK Stock Market Today: FTSE 100 Slides as Oil Jumps, BoE Cut Bets Take Another Hit

London’s FTSE 100 dropped 0.7% in early trade Thursday as Brent crude topped $100 a barrel following new Gulf shipping attacks. Travel firm On the Beach suspended its profit forecast, citing weaker holiday demand tied to Middle East conflict. Legal & General shares fell 5% after missing profit targets. TP ICAP rose 3.5% on stronger trading results.
12 March 2026
···········
UBS spots a 2026 turning point for UK and European stocks — and names Aviva, NatWest among top themesNEW YORK, December 29, 2025, 06:34 ET

UBS spots a 2026 turning point for UK and European stocks — and names Aviva, NatWest among top themesNEW YORK, December 29, 2025, 06:34 ET

UBS expects UK and European equities to return to earnings growth in 2026, forecasting a 7% rise in average earnings per share. Britain’s FTSE 100 has gained 20.7% this year, outpacing the STOXX 600 and S&P 500. UBS highlighted insurers Aviva and Admiral, and cited NatWest and RELX among UK companies with structural tailwinds. The bank remains cautious on autos, chemicals, and household products.
29 December 2025
···

Stock Market Today

  • Bitmine Immersion Technologies Uplists to NYSE, Holds 5M+ ETH as Ethereum Proxy, Launches MAVAN Staking
    May 21, 2026, 12:11 AM EDT. Bitmine Immersion Technologies (NYSE:BMNR) has become a major Ethereum proxy by accumulating over 5 million ETH, representing more than 4.3% of Ethereum's total supply. The company uplisted to the NYSE and introduced MAVAN, an institutional-grade Ethereum staking platform, shifting its focus beyond mining to include staking services. BMNR stock closed at $19.39, trading below analyst targets and experiencing recent price declines despite longer-term gains. Investors should watch Ethereum price trends, staking yields, and institutional adoption of MAVAN, while noting BMNR remains loss-making and has diluted shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop